MX3277E - Procedimiento para la preparacion de derivados de eritromicina - Google Patents
Procedimiento para la preparacion de derivados de eritromicinaInfo
- Publication number
- MX3277E MX3277E MX000145U MX14576U MX3277E MX 3277 E MX3277 E MX 3277E MX 000145 U MX000145 U MX 000145U MX 14576 U MX14576 U MX 14576U MX 3277 E MX3277 E MX 3277E
- Authority
- MX
- Mexico
- Prior art keywords
- group
- carbon atoms
- moiety
- alcohol
- general formula
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 17
- 125000003158 alcohol group Chemical group 0.000 abstract 8
- 230000001476 alcoholic effect Effects 0.000 abstract 8
- -1 phenylmercapto group Chemical group 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 abstract 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000002071 phenylalkoxy group Chemical group 0.000 abstract 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a un procedimiento para la preparación de derivados de eritromicina de las fórmulas I, IA y Ib; (ver gaceta) en las que R posee los siguientes significados: el grupo hidroxi, el grupo fenoxi, un grupo fenilalcoxi con 1 a 3 átomos de carbono en la porción alcohileno, un grupo alcoxi con 1 a 4 átomos de carbono, un grupo hidroxialcoxi, alcoxialcoxi, dialcohilaminoalcoxi o alcoxicarbonilalcoxi con 1 a 4 átomos de carbono en la porción alcohileno y 1 a 3 átomos de carbono en la porción alcohilo, el grupo mercapto, el grupo fenilmercapto, que eventualmente puede estar sustituido con grupos metilo, metoxi, etoxi isopropoxi o propoxi, un grupo fenilalcohilmercapto con 1 a 3 átomos de carbono en la porción alcohileno, un grupo alcohilmercapto de cadena recta o ramificada con 1 a 5 átomos de carbono, el grupo ciclohexilmercapto, un grupo hidroxialcohilmercato, dialcohilaminoalcohilmercapto, alcoxicarbonilalcohilmercapto o cianoalcohilmercapto en cada caso con 1 a 3 átomos de carbono en la porción alcohileno y en la porción alcohilo, un grupo amino de la fórmula general -NR2R3, en la queØR2 y R3, que pueden ser iguales o diferentes entre sí, representan átomos de hidrógeno, grupos fenilo, grupos fenilalcohilo con 1 a 3 átomos de carbono en la porción alchoileno, grupos alcohilo con 1 a 4 átomos de carbono, pudiendo formar los grupos alcohilo también conjuntamente con el átomo de nitrógeno situado entre medias un anillo heterocíclico monocíclico de 5 ó 6 miembros, que eventualmente puede estar interrumpido por un átomo de oxígeno o de azufre o por otro átomo de nitrógeno; un radical aciloxi de la fórmula general (ver gaceta), en la que R4 significa un grupo alcohilo de cadena recta o ramificada con 1 a 5 átomos de carbono, el grupo bencilo o el grupo fenilo; un grupo amido de la fórmula general -NH-CO-R5, en la que R5 significa un grupo alcohilo de cadena recta o ramificada con 1 a 5 átomos de carbono, que eventualmente puede estar sustituído con 1 ó 2 átomos de halógeno o con un grupo ciano, un grupo fenilalcohilo con 1 a 3 átomos de carbono en la porción alcohileno, que puede estar sustituído eventualmente en el radical fenilo con 1 ó 2 átomos de halógeno o un grupo metoxi y en la porción alcohileno con un átomo de halógeno, un radical fenoxiacohilo con 1 a 3 átomos de carbono en la porción alcohileno, un grupo fenilalquenilo con 2 a 4 átomos de carbono en la porción alquenileno, un grupo fenilo que eventualmente puede estar sustituído con uno o varios grupos metilo, hidroxi, metoxi o nitro o átomos de cloro; el grupo piridilo, furilo, fluorofurilo o tienilo, el radical N-fenilcarbamoílo, un radical carboxamido-metiloxi de la fórmula general (gaceta) en la que R6 y R7, que pueden ser iguales o diferentes entre sí, significan el grupo metilo, etilo, propilo o isopropilo, o un grupo dialcohilfosfono de la fórmula general(R8O)2-P en la que R8 representa un grupo alcohilo de cadena recta o ramificada con 1 a 5 átomos de carbono; un grupo sulfonamido de la fórmula general -NH-SO2-R9, en la que R9 significa un grupo alcohilo con 1 a 4 átomos de carbono o al radical fenilo eventualmente sustituído con un grupo alcohilo con 1 a 3 átomos de carbono,(ver gaceta)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2515075A DE2515075C2 (de) | 1975-04-07 | 1975-04-07 | Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19762606030 DE2606030A1 (de) | 1976-02-14 | 1976-02-14 | Neue erythromycinderivate und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX3277E true MX3277E (es) | 1980-08-15 |
Family
ID=25768725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX000145U MX3277E (es) | 1975-04-07 | 1976-04-06 | Procedimiento para la preparacion de derivados de eritromicina |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US4048306A (es) |
| JP (1) | JPS51128991A (es) |
| AT (1) | AT342770B (es) |
| AU (1) | AU498418B2 (es) |
| BG (1) | BG27380A3 (es) |
| CA (1) | CA1060005A (es) |
| CH (2) | CH621800A5 (es) |
| CS (1) | CS196304B2 (es) |
| DD (1) | DD125218A5 (es) |
| DK (1) | DK138656C (es) |
| ES (2) | ES446737A1 (es) |
| FI (1) | FI63244C (es) |
| FR (1) | FR2306703A1 (es) |
| GB (1) | GB1520963A (es) |
| GR (1) | GR60374B (es) |
| HU (1) | HU175186B (es) |
| IE (1) | IE43598B1 (es) |
| IL (1) | IL49359A (es) |
| LU (2) | LU88563I2 (es) |
| MX (1) | MX3277E (es) |
| NL (1) | NL180107C (es) |
| NO (1) | NO141411C (es) |
| NZ (1) | NZ180529A (es) |
| PL (1) | PL101880B1 (es) |
| PT (1) | PT64977B (es) |
| RO (1) | RO68441B (es) |
| SE (1) | SE425566B (es) |
| SU (1) | SU682134A3 (es) |
| YU (1) | YU87676A (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT82162B (en) | 1985-03-12 | 1987-08-06 | Beecham Group Plc | Chemical compounds |
| DE3524572A1 (de) * | 1985-07-10 | 1987-01-15 | Thomae Gmbh Dr K | Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung |
| US5110800A (en) * | 1986-02-18 | 1992-05-05 | Eli Lilly And Company | Derivatives of erythromycylamine |
| US4945080A (en) * | 1987-05-26 | 1990-07-31 | Eli Lilly And Company | Dirithromycin metabolite |
| US5075289A (en) * | 1988-06-07 | 1991-12-24 | Abbott Laboratories | 9-r-azacyclic erythromycin antibiotics |
| WO1992009614A1 (fr) * | 1990-11-28 | 1992-06-11 | Taisho Pharmaceutical Co., Ltd. | Derive de 6-o-methylerythromycine a |
| US5556839A (en) * | 1991-04-29 | 1996-09-17 | Eli Lilly And Company | Form II Dirithromycin |
| ZA922777B (en) * | 1991-04-29 | 1993-10-15 | Lilly Co Eli | Pharmaceutical formulation containing dirithromycin |
| CZ281664B6 (cs) * | 1991-09-30 | 1996-12-11 | Eli Lilly And Company Patent Division Lilly Corporate Center | Způsob jednostupňové přípravy dirithromycinu |
| DE4410637C1 (de) * | 1994-03-26 | 1995-09-21 | Boehringer Ingelheim Vetmed | Injizierbare Lösungen von Dirithromycin |
| WO1999021867A1 (fr) * | 1997-10-29 | 1999-05-06 | Taisho Pharmaceutical Co., Ltd. | Derives d'erythromycine a |
| US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
| US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
| US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| US6436906B1 (en) | 2001-04-02 | 2002-08-20 | Enanta Pharmaceuticals, Inc. | 9-amino-14-membered macrolides derived from leucomycins |
| EP1648418A4 (en) | 2003-07-21 | 2011-11-16 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION |
| CA2533178C (en) | 2003-07-21 | 2014-03-11 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
| EP1648407A4 (en) | 2003-07-21 | 2011-08-31 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION |
| JP2007502296A (ja) | 2003-08-11 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | ロバストペレット |
| EP1653924A4 (en) | 2003-08-12 | 2009-09-09 | Middlebrook Pharmaceuticals In | ANTIBIOTICS, USE AND FORMULATION ASSOCIATED |
| EP1658034A4 (en) * | 2003-08-29 | 2011-06-22 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION |
| WO2005027877A1 (en) | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
| AU2005269981A1 (en) | 2004-07-02 | 2006-02-09 | Bonck, John A | Tablet for pulsed delivery |
| US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
| US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
| US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3660376A (en) * | 1970-09-30 | 1972-05-02 | Lilly Co Eli | N-arylidene erythromycylamines |
-
1976
- 1976-03-01 AT AT149976A patent/AT342770B/de not_active IP Right Cessation
- 1976-03-26 GR GR50399A patent/GR60374B/el unknown
- 1976-03-29 BG BG032727A patent/BG27380A3/xx unknown
- 1976-03-29 US US05/671,421 patent/US4048306A/en not_active Expired - Lifetime
- 1976-03-30 FI FI760845A patent/FI63244C/fi not_active IP Right Cessation
- 1976-03-30 DK DK145276A patent/DK138656C/da not_active IP Right Cessation
- 1976-04-02 CH CH417476A patent/CH621800A5/de not_active IP Right Cessation
- 1976-04-05 DD DD192208A patent/DD125218A5/xx unknown
- 1976-04-05 LU LU88563C patent/LU88563I2/fr unknown
- 1976-04-05 LU LU74702A patent/LU74702A1/xx unknown
- 1976-04-06 MX MX000145U patent/MX3277E/es unknown
- 1976-04-06 NZ NZ180529A patent/NZ180529A/xx unknown
- 1976-04-06 PL PL1976188538A patent/PL101880B1/pl unknown
- 1976-04-06 IL IL49359A patent/IL49359A/xx unknown
- 1976-04-06 RO RO85433A patent/RO68441B/ro unknown
- 1976-04-06 YU YU00876/76A patent/YU87676A/xx unknown
- 1976-04-06 ES ES446737A patent/ES446737A1/es not_active Expired
- 1976-04-06 NO NO761172A patent/NO141411C/no unknown
- 1976-04-06 HU HU76TO1026A patent/HU175186B/hu unknown
- 1976-04-06 AU AU12722/76A patent/AU498418B2/en not_active Expired
- 1976-04-06 SE SE7604052A patent/SE425566B/xx not_active IP Right Cessation
- 1976-04-06 PT PT64977A patent/PT64977B/pt unknown
- 1976-04-06 NL NLAANVRAGE7603569,A patent/NL180107C/xx not_active IP Right Cessation
- 1976-04-06 JP JP51038681A patent/JPS51128991A/ja active Granted
- 1976-04-06 GB GB13942/76A patent/GB1520963A/en not_active Expired
- 1976-04-06 CS CS762265A patent/CS196304B2/cs unknown
- 1976-04-06 SU SU762343016A patent/SU682134A3/ru active
- 1976-04-06 CA CA249,700A patent/CA1060005A/en not_active Expired
- 1976-04-07 IE IE732/76A patent/IE43598B1/en not_active IP Right Cessation
- 1976-04-07 FR FR7610144A patent/FR2306703A1/fr active Granted
-
1977
- 1977-03-05 ES ES456567A patent/ES456567A1/es not_active Expired
-
1980
- 1980-04-10 CH CH277580A patent/CH624413A5/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX3277E (es) | Procedimiento para la preparacion de derivados de eritromicina | |
| JPS51115478A (en) | Piperidine derivatives acid addidion salt and optical isomer | |
| ES462062A1 (es) | Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina. | |
| ES403503A1 (es) | Procedimiento para la preparación de derivados de piperidina y su utilizacion como estabilizadores | |
| ES278320A1 (es) | Procedimiento para la preparación de compuestos de poliadición estables a la luz | |
| AR023308A1 (es) | Uso de dihidropirimidinas para la preparacion de un medicamento, dihidropirimidinas, procedimiento para su produccion y preparados farmaceuticos que loscontienen. | |
| SE422824B (sv) | Anordning vid forbrenningsmotorer | |
| ES387016A1 (es) | Un procedimiento para la preparacion de derivado de isoqui-nolina. | |
| BG26526A3 (bg) | Метод за получаване на 1-(бензазолилалкил)пиперидинови производни | |
| SE7604593L (sv) | Anordning vid en overladdad forbrenningmotor | |
| ES470861A1 (es) | Procedimiento de preparacion de derivados de benzoil-2 clo- ro-4 glicinanilidas | |
| SE422839B (sv) | Anordning for forbrenning av foreddade brenslen | |
| DK340476A (da) | Thiazolidinderivater og fremgangsmade til deres fremstilling | |
| DK219488D0 (da) | Benzo- og thieno-3,4-dihydropyridinderivater, deres fremstilling og laegemidler indeholdende forbindelserne | |
| DK153141C (da) | Aminophenoler til anvendelse som braendstof- eller smoeremiddeladditiv og deres anvendelse som braendstof- eller smoeremiddeladditiv | |
| ES369746A1 (es) | Procedimiento de obtencion de derivados de aminopiperidina. | |
| ES452648A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina. | |
| SE7607300L (sv) | Tiaxantenforeningar samt forfarande for framstellning av dem | |
| ES410934A1 (es) | Procedimiento para la preparacion de acidos indolcarboxili-cos. | |
| ES383467A1 (es) | Procedimiento para la preparacion de derivados de pirrol. | |
| ES428600A1 (es) | Procedimiento de preparacion de fenilpiperazino-1 amino-3 propanoles-2. | |
| SE7509438L (sv) | Anordning vid inmatningsbenkar for kantverk | |
| ES420760A1 (es) | Procedimiento para laobtencion de composiciones desensibi- lizadoras. | |
| ES426329A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1,2,3,4-tetrahidroisoquinoleina. | |
| ES280829A1 (es) | Procedimiento de preparación de derivados de la amino-4 quinoleína |